Ownership history in BRIDGEWAY CAPITAL MANAGEMENT, LLC · 44 quarters on record
This page tracks every 13F SEC filing in which BRIDGEWAY CAPITAL MANAGEMENT, LLC reported a position in PROTALIX BIOTHERAPEUTICS INC (PLX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 189,100 | — | 0% | 0.01% | $340K | $1.80 |
| 2025 Q3 | UNCHANGED | 189,100 | — | 0% | 0.01% | $420K | $2.22 |
| 2025 Q2 | UNCHANGED | 189,100 | — | 0% | 0.01% | $280K | $1.48 |
| 2025 Q1 | ADDED | 189,100 | +7,700 | +4.2% | 0.01% | $484K | $2.56 |
| 2024 Q4 | REDUCED | 181,400 | -2,390 | -1.3% | 0.01% | $341K | $1.88 |
| 2024 Q3 | UNCHANGED | 183,790 | — | 0% | 0.00% | $187K | $1.02 |
| 2024 Q2 | UNCHANGED | 183,790 | — | 0% | 0.01% | $215K | $1.17 |
| 2024 Q1 | REDUCED | 183,790 | -25,000 | -12.0% | 0.00% | $232K | $1.26 |
| 2023 Q4 | ADDED | 208,790 | +50,000 | +31.5% | 0.01% | $372K | $1.78 |
| 2023 Q3 | UNCHANGED | 158,790 | — | 0% | 0.01% | $264K | $1.66 |
As of 2025 Q4 — sorted by position size